2-165386976-G-C
Variant summary
Our verdict is Likely pathogenic. Variant got 10 ACMG points: 10P and 0B. PM5_SupportingPS1_ModeratePM6PM2_SupportingPS4_ModeratePP3_Moderate
This summary comes from the ClinGen Evidence Repository: The c.4782G>C variant in SCN2A is a missense variant predicted to cause substitution of tryptophan by cysteine at amino acid 1594 (p.Trp1594Cys). The variant has been identified in multiple individuals meeting criteria for complex neurodevelopmental disorder (PS4, PM6)(PMID:34004075, internal lab contributors). It is absent from the population database gnomAD v2.1.1 and v4.1.0 (PM2_Supporting). The computational predictor REVEL gives a score of 0.924, which is above the threshold of 0.773, evidence that correlates with a maximum strength of PP3_Moderate. The same amino acid change (p.Trp1594Cys), resulting from a different nucleotide change[c.4782G>T](PMID:35365919, PMID:23603762) is classified as likely pathogenic for complex neurodevelopmental disorder by the ClinGen Epilepsy Sodium Channel VCEP(PS1_Moderate). Additionally, another missense variant in the same codon c.4780T>A, p.Trp1594Arg reaches likely pathogenic based on current criteria (PM5_Supporting). In summary, this variant meets the criteria to be classified as likely pathogenic for autosomal dominant complex neurodevelopmental disorder based on the ACMG/AMP criteria applied, as specified by the ClinGen Epilepsy Sodium Channel VCEP: PS4_Moderate, PM6, PS1_Moderate, PM2_Supporting, PP3_Moderate, PM5_Supporting. (version 1.0; November 26, 2024). LINK:https://erepo.genome.network/evrepo/ui/classification/CA16603919/MONDO:0100038/068
Frequency
Consequence
NM_001040142.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCN2A | ENST00000375437.7 | c.4782G>C | p.Trp1594Cys | missense_variant | Exon 26 of 27 | 5 | NM_001040142.2 | ENSP00000364586.2 | ||
SCN2A | ENST00000631182.3 | c.4782G>C | p.Trp1594Cys | missense_variant | Exon 26 of 27 | 5 | NM_001371246.1 | ENSP00000486885.1 | ||
SCN2A | ENST00000283256.10 | c.4782G>C | p.Trp1594Cys | missense_variant | Exon 26 of 27 | 1 | ENSP00000283256.6 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:1
A W1594C variant that is likely pathogenic has been identified in the SCN2A gene. A different nucleotide substitution (c.4782 G>T) resulting in the same amino acid change, W1594C, has been reported previously as a de novo variant in an individual with neonatal seizures, intellectual disability, and polymicrogyria; this individual also had a de novo variant in the RAI1 gene (Poirier et al., 2013). It was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The W1594C variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a conserved position predicted to be within transmembrane segment S3 in the fourth homologous domain of the SCN2A protein, and missense variants in nearby residues (G1593R, D1598G) have been reported in the Human Gene Mutation Database in association with SCN2A-related disorders (Stenson et al., 2014). In silico analysis predicts this variant is probably damaging to the protein structure/function. Therefore, this variant is likely pathogenic; however, the possibility that it is benign cannot be excluded. -
Inborn genetic diseases Uncertain:1
The p.W1594C variant (also known as c.4782G>C), located in coding exon 25 of the SCN2A gene, results from a G to C substitution at nucleotide position 4782. The tryptophan at codon 1594 is replaced by cysteine, an amino acid with highly dissimilar properties. In one study which performed exome sequencing on individuals with cortical malformations, this alteration was detected as a de novo occurrence in an individual with neonatal seizures and perisylvian polymicrogyria who also carried the de novo RAI1 p.L855P alteration. It is unclear whether this individual's epilepsy phenotype is due to their genotype or their cortical malformation (Poirier K et al. Nat. Genet., 2013 Jun;45:639-47).This variant was not reported in population based cohorts in the following databases: Database of Single Nucleotide Polymorphisms (dbSNP), NHLBI Exome Sequencing Project (ESP), and 1000 Genomes Project. In the ESP, this variant was not observed in 6503 samples (13006 alleles) with coverage at this position. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at